| http://www.w3.org/ns/prov#value | - In addition, the results of these studies also suggest that inhibition of 11beta-HSD1 will be a viable strategy for treating metabolic diseases such as type 2 diabetes, obesity, and the metabolic syndrome.Lending further support to this idea are the results of a series of preliminary clinical studies.
|
